NCT04005690
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +13 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Clinical trial condition
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Explore clinical trials studying Borderline Resectable Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
11 public trials
8 recruiting studies
Borderline Resectable Pancreatic Ductal Adenocarcinoma trial results
NCT07645651
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT07619313
- Conditions
- Adenocarcinoma, Borderline Resectable Pancreatic Ductal Adenocarcinoma, Carcinoma, +18 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
NCT06423326
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT06821997
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Recruiting
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
NCT06574620
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, +1 more
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada
NCT07269626
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +8 more
- Locations
-
- Samsung Medical Center Seoul, Select Province/State, South Korea
NCT06595160
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +8 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
Not yet recruiting
SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial
NCT07748611
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma
- Locations
-
- Northwestern University Chicago, Illinois, United States
Not yet recruiting
DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer
NCT07705919
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States